Johnny Huard
Steadman Philippon Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Johnny Huard as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:35 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07918261 · Evaluation of Fisetin to Reduce Systemic SenescenceSteadman Philippon Research Institute · completed · Cellular Senescence · principal investigator
- Ph1/Ph2NCT06108063 · Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using LosartanSteadman Philippon Research Institute · recruiting · Knee Arthroplasty, Total · principal investigator
- Ph1/Ph2NCT04815902 · Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for OsteoarthritisSteadman Philippon Research Institute · unknown · Osteoarthritis, Knee · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 13 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for OsteoarthritisUH3AR077748 · NIAMS · STEADMAN PHILIPPON RESEARCH INSTITUTE · fiscal years 2021 to 2024 · $551,586 awarded in 2024Same name and institution; not confirmed by an ID
- SMART stem cells that autonomously down-modulate TFG-β signaling for Articular Cartilage RepairR21AR079075 · NIAMS · STEADMAN PHILIPPON RESEARCH INSTITUTE · fiscal years 2022 to 2023 · $155,115 awarded in 2023Same name and institution; not confirmed by an ID
- The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for OsteoarthritisUG3AR077748 · NIAMS · STEADMAN PHILIPPON RESEARCH INSTITUTE · fiscal years 2020 · $522,288 awarded in 2020Grant number is on one of their registry trials
- Effects of Circulating Factors and Progenitors on Wound Healing during PregnancyR21AR073509 · NIAMS · STEADMAN PHILIPPON RESEARCH INSTITUTE · fiscal years 2018 to 2019 · $172,150 awarded in 2019Same name and institution; not confirmed by an ID
- Muscle Stem Cells Reprogrammed Through Genome Engineering for Autonomously Regulated Anti-Fibrotic TherapyR21AR072870 · NIAMS · STEADMAN PHILIPPON RESEARCH INSTITUTE · fiscal years 2018 to 2019 · $204,154 awarded in 2019Same name and institution; not confirmed by an ID
- Bone Abmormalities and Healing Defect in Muscular DystrophyR01AR065445 · NIAMS · STEADMAN PHILIPPON RESEARCH INSTITUTE · fiscal years 2014 to 2018 · $344,300 awarded in 2018Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:35 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.Cell Transplant · 1993277 citationsRCR 6.5
- 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence.Int Urogynecol J Pelvic Floor Dysfunct · 2008182 citationsRCR 5.6